Fargo, ND, United States of America

Sheela Ramamoorthy

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Ndsu-Research Foundation. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sheela Ramamoorthy. Retrieved from https://idiyas.com/inventor/sheela-ramamoorthy-agl2b11n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sheela Ramamoorthy: Innovator in Viral Vaccine Development

Introduction

Sheela Ramamoorthy is a prominent inventor based in Fargo, ND (US). She has made significant contributions to the field of viral vaccine development. With a focus on innovative methods for producing inactivated viruses, her work has the potential to impact public health positively.

Latest Patents

Sheela holds 2 patents related to viral vaccines. Her latest patents include methods for producing inactivated viruses. The first patent outlines a method that involves heating the virus to disrupt its membrane, exposing it to a nucleic acid degrading enzyme, and then cooling it to restore the membrane's integrity. The second patent follows a similar approach but utilizes an RNA degrading enzyme instead. Both patents also describe vaccines produced using these methods.

Career Highlights

Sheela Ramamoorthy is associated with the NDSU Research Foundation, where she continues her research and development efforts. Her work is characterized by a commitment to advancing vaccine technology and improving public health outcomes.

Conclusion

Sheela Ramamoorthy's innovative approaches to viral vaccine development highlight her role as a key inventor in the field. Her contributions are paving the way for new methods in vaccine production, which could have lasting benefits for global health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…